Our passion for creating meaningful change for patients is what sets us apart. The iFocus team believes in the potential of our great idea, and it truly shows in all of our work. We work tirelessly in order to bring you a better tomorrow, and we’re proud of every single member of staff.
iFocus Health empowers patients and caregivers with data-driven insights for informed ADHD treatment decisions. Our cutting-edge technology relieves the burden of decision-making, omits the guesswork, and leads to better outcomes for people with ADHD. Our mission is to transform ADHD treatment with an innovative, effective, and easy-to-use tool.
Yulie brings 12 years of expertise in medical devices, genomics, wearables, connected devices, Health IT, and AI/ML. Among her competencies are Product Roadmap and P&L Ownership, Market Access Strategy Development, and Competitive Positioning Analysis.
She demonstrates a strong track record in building partnerships with key healthcare stakeholders such as Cigna, United Healthcare, Anthem, Kaiser Healthcare, Merck, Abbvie, Novartis, Sanofi, and GSK.
Dr. Cheyette is Board-Certified in Psychiatry with over twenty years of practice treating a wide variety of patients including those with depression. He loves general psychiatry and has a clinical interest and expertise in adult ADHD.
He received his medical degree from the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) while simultaneously completing a PhD in Molecular Biology, both fully funded by an NIH scholarship.
Having spent several decades in academia as a research scientist, Dr. Benjamin Cheyette is interested in cutting-edge innovations such as Transcranial Magnetic Stimulation (TMS), the emerging field of psychedelic medicine, and applying these treatments to patient care in an evidence-based manner.
Sarah Cheyette is a pediatric neurologist—a doctor who specializes in brains. She loves treating ADHD patients because it is so rewarding to make interventions that can change a trajectory toward success.
Sarah Cheyette graduated cum laude in Cognitive Neuroscience from Princeton University and received her medical degree from the UCLA David Geffen School of Medicine. Following specialty training in pediatrics at Cedars-Sinai Medical Center in Los Angeles and in pediatric neurology at Seattle Children’s Hospital she now practices at the Palo Alto Medical Foundation where she focuses on treating ADHD in both children and adults. For the last 5 years, she has been a “Top Doctor” in San Francisco magazine.
She has written three books on ADHD which explain its common behavioral symptoms, the biology behind it, and what research has revealed about it – as well as issues faced by parents when considering prescription medications and other approaches to treatment.
Dr. Elliott, a board-certified child and adolescent psychiatrist, has been involved in diagnosing, treating, and doing research on children and adolescents with ADHD since 1984. He was Director of The Children’s Center at Langley Porter at UCSF for over 17 years, retiring in 2006 as Emeritus Professor of Clinical Psychiatry.
From 2006 until his retirement last June, he was Chief Psychiatrist and Medical Director at the Children’s Health Council (CHC), and he remains a Professor of Clinical Psychiatry (Affiliated) in the Stanford School of Medicine Department of Psychiatry and Behavioral Sciences. He was a co-principal investigator at one of 6 sites for the Multimodal Treatment of ADHD (MTA) and was actively involved in researching, diagnosing and treating ADHD throughout his career.
He has had a lifelong interest in better understanding how the brain works, especially with regard to psychiatric disorders, with a particular focus on brain chemistry and the appropriate use of medications to alleviate severe behavior disturbances.
A board-certified child and adult psychiatrist and world authority on ADHD. He is a graduate of Harvard College and Tulane Medical School and was a Harvard Medical School faculty member for 21 years. He is the Founder of The Hallowell ADHD Centers in Boston MetroWest, New York City, San Francisco, Palo Alto, and Seattle.
Chief Commercial Officer
Guy is a seasoned entrepreneur with more than 25 years of experience in biotech startups.
A founder and board member in NRGene (TASE:NRGN), which he helped grow to more than 10M$ of annual sales. Started as NRGene’s VP of R&D
And later served as VP product and VP of strategic alliances.
Guy has B.Sc in Computer science and biology, followed by an M.Sc. in Human genetics.
CPO & Co-Founder
Ravid brings over 15 years of product management experience, building features and platforms for various digital health initiatives.
She is experienced in driving multidisciplinary teams to bring product vision and strategy to launch while improving patients’ lives.
Ravid holds a B.Sc. in computer science and an MBA with health care focus from Duke University.
CEO & Co-Founder
Adi has a Ph.D. in Physics from the Weizmann Institute of Science. Over the past 20 years, Adi has been leading the development of lasers, biotech, and medical devices. Adi’s expertise is finding original practical solutions for complex nearly impossible problems.
A mother to a kid with ADHD and an ADHDier, Adi applies her passion for learning and out of the box thinking to find ways to improve the treatment for individuals with ADHD.
